Prokineticin 2 is an endangering mediator of cerebral ischemic injury

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 14, 2012, Pages 5475-5480

  Cheng, Michelle Y ^a   Lee, Alex G ^a   Culbertson, Collin ^a   Sun, Guohua ^a   Talati, Rushi K ^a   Manley, Nathan C ^a   Li, Xiaohan ^b   Zhao, Heng ^a   Lyons, David M ^a   Zhou, Qun Yong ^b   Steinberg, Gary K ^a   Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; Erk1,2; Excitotoxicity; RNA interference; SAP JNK

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GLUTAMIC ACID; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROKINETICIN 2; PROKINETICIN 2 RECEPTOR; PROKINETICIN 2 RECEPTOR ANTAGONIST; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL HYPOXIA; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE EXACERBATION; ENCEPHALITIS; EXCITOTOXICITY; EXPERIMENTAL MODEL; EXTRACELLULAR CALCIUM; GENE EXPRESSION; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL CULTURE; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RNA INTERFERENCE; SINGLE DRUG DOSE; STROKE; UPREGULATION;

ANIMALS; BRAIN ISCHEMIA; GASTROINTESTINAL HORMONES; NEUROPEPTIDES; RATS; RNA, MESSENGER; UP-REGULATION;

EID: 84859471538     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113363109     Document Type: Article

References (51)

1. Lloyd-Jones D, et al.; WRITING GROUP MEMBERS; American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2010) Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121:e46-e215.
2. Sapolsky RM (2003) Neuroprotective gene therapy against acute neurological insults. Nat Rev Neurosci 4:61-69.
3. Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232-245. (Pubitemid 44279808)
4. Carmichael ST (2003) Gene expression changes after focal stroke, traumatic brain and spinal cord injuries. Curr Opin Neurol 16:699-704.
5. Lu XC, et al. (2004) Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res 77:843-857.
6. Carmichael ST, et al. (2005) Growth-associated gene expression after stroke: Evidence for a growth-promoting region in peri-infarct cortex. Exp Neurol 193:291-311. (Pubitemid 40616180)
7. Iadecola C, Ross ME (1997) Molecular pathology of cerebral ischemia: Delayed gene expression and strategies for neuroprotection. Ann N Y Acad Sci 835:203-217. (Pubitemid 28046108)
8. Kinouchi H, Huang H, Arai S, Mizoi K, Yoshimoto T (1999) Induction of cyclooxygenase-2 messenger RNA after transient and permanent middle cerebral artery occlusion in rats: Comparison with c-fos messenger RNA by using in situ hybridization. J Neurosurg 91:1005-1012.
9. Sairanen T, et al. (1998) Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol 43:738-747. (Pubitemid 28280217)
10. Lansberg MG, Bluhmki E, Thijs VN (2009) Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: A metaanalysis. Stroke 40:2438-2441.
11. Lees KR, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group (2010) Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695-1703.
12. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY (2001) Identification of two prokineticin cDNAs: Recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 59:692-698. (Pubitemid 32273997)
13. Kaser A, Winklmayr M, Lepperdinger G, Kreil G (2003) The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep 4:469-473. (Pubitemid 36789844)
14. Cheng MY, et al. (2002) Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417:405-410. (Pubitemid 34563527)
15. Li JD, et al. (2006) Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 26:11615-11623.
16. Maywood ES, et al. (2007) Genetic and molecular analysis of the central and peripheral circadian clockwork of mice. Cold Spring Harb Symp Quant Biol 72:85-94.
17. LeCouter J, et al. (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412:877-884.
18. LeCouter J, et al. (2003) The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 100:2685-2690. (Pubitemid 36297559)
19. Tanaka N, Ikawa M, Mata NL, Verma IM (2006) Choroidal neovascularization in transgenic mice expressing prokineticin 1: An animal model for age-related macular degeneration. Mol Ther 13:609-616. (Pubitemid 43257629)
20. Ng KL, et al. (2005) Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 308:1923-1927. (Pubitemid 40941878)
21. Cottrell GT, Zhou QY, Ferguson AV (2004) Prokineticin 2 modulates the excitability of subfornical organ neurons. J Neurosci 24:2375-2379. (Pubitemid 38327950)
22. Ingves MV, Ferguson AV (2010) Prokineticin 2 modulates the excitability of area postrema neurons in vitro in the rat. Am J Physiol Regul Integr Comp Physiol 298:R617-R626.
23. Yuill EA, Hoyda TD, Ferri CC, Zhou QY, Ferguson AV (2007) Prokineticin 2 depolarizes paraventricular nucleus magnocellular and parvocellular neurons. Eur J Neurosci 25:425-434.
24. Xiong YC, et al. (2010) Prokineticin 2 suppresses GABA-activated current in rat primary sensory neurons. Neuropharmacology 59:589-594.
25. Martucci C, et al. (2006) Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br J Pharmacol 147:225-234. (Pubitemid 43151571)
26. Mollay C, et al. (1999) Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol 374:189-196. (Pubitemid 29287133)
27. Negri L, et al. (2002) Nociceptive sensitization by the secretory protein Bv8. Br J Pharmacol 137:1147-1154. (Pubitemid 36071731)
28. Giannini E, et al. (2009) The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci USA 106:14646-14651.
29. Pitteloud N, et al. (2007) Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 104:17447-17452. (Pubitemid 350219858)
30. Maldonado-Pérez D, Evans J, Denison F, Millar RP, Jabbour HN (2007) Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab 18:66-72. (Pubitemid 46275457)
31. Matsumoto S, et al. (2006) Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 103:4140-4145.
32. Melchiorri D, et al. (2001) The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways. Eur J Neurosci 13:1694-1702. (Pubitemid 32488059)
33. Urayama K, et al. (2008) Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation. Arterioscler Thromb Vasc Biol 28:841-849. (Pubitemid 351544097)
34. Malyala P, Singh M (2008) Endotoxin limits in formulations for preclinical research. J Pharm Sci 97:2041-2044.
35. Balboni G, et al. (2008) Triazine compounds as antagonists at Bv8-prokineticin receptors. J Med Chem 51:7635-7639.
36. Bullock CM, Li JD, Zhou QY (2004) Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol 65:582-588. (Pubitemid 38264025)
37. Zhang X, et al. (2010) Temporal and spatial differences of multiple protein expression in the ischemic penumbra after transient MCAO in rats. Brain Res 1343:143-152.
38. Lin DC, et al. (2002) Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 277:19276-19280. (Pubitemid 34967431)
39. Masuda Y, et al. (2002) Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun 293:396-402. (Pubitemid 34694220)
40. Soga T, et al. (2002) Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 1579:173-179. (Pubitemid 35341439)
41. Zhao H, et al. (2005) Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 25:9794-9806. (Pubitemid 41510919)
42. Zhao H, Sapolsky RM, Steinberg GK (2006) Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34:249-270.
43. Li B, Xu W, Luo C, Gozal D, Liu R (2003) VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res Mol Brain Res 111:155-164. (Pubitemid 36332339)
44. Sawe N, Steinberg G, Zhao H (2008) Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 86:1659-1669. (Pubitemid 351859418)
45. An J, et al. (2008) Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 112:2787-2794.
46. Di Lorenzo A, Fernández-Hernando C, Cirino G, Sessa WC (2009) Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci USA 106:14552-14557.
47. Irving EA, Bamford M (2002) Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647. (Pubitemid 34596455)
48. Gelderblom M, et al. (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40:1849-1857.
49. Han HS, Yenari MA (2003) Cellular targets of brain inflammation in stroke. Curr Opin Investig Drugs 4:522-529. (Pubitemid 36717196)
50. Zhou QY, Cheng MY (2005) Prokineticin 2 and circadian clock output. FEBS J 272:5703-5709.
51. Choke E, et al. (2009) Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 37:305-310.